Stock News

As Humana (Call) (HUM) Valuation Rose, Shareholder Partner Fund Management LP Has Decreased by $29.51 Million Its Holding; Pfizer (PFE) Holding Upped by Walter & Keenan Financial Consulting Company

Pfizer Inc. (NYSE:PFE) Logo

Christopher Medlock James decreased its stake in Humana Inc (Call) (HUM) by 59.14% based on its latest 2017Q4 regulatory filing with the SEC. Partner Fund Management Lp sold 118,990 shares as the company’s stock rose 9.24% while stock markets declined. The hedge fund run by Christopher Medlock James held 82,200 shares of the medical specialities company at the end of 2017Q4, valued at $20.39 million, down from 201,190 at the end of the previous reported quarter. Partner Fund Management Lp who had been investing in Humana Inc (Call) for a number of months, seems to be less bullish one the $41.16 billion market cap company. The stock increased 1.21% or $3.55 during the last trading session, reaching $298.05. About 124,534 shares traded. Humana Inc. (NYSE:HUM) has risen 31.54% since April 24, 2017 and is uptrending. It has outperformed by 19.99% the S&P500.

Walter & Keenan Financial Consulting Company increased its stake in Pfizer Inc (PFE) by 962.45% based on its latest 2017Q4 regulatory filing with the SEC. Walter & Keenan Financial Consulting Company bought 1.18M shares as the company’s stock declined 3.13% with the market. The institutional investor held 1.30M shares of the health care company at the end of 2017Q4, valued at $4.72 million, up from 122,473 at the end of the previous reported quarter. Walter & Keenan Financial Consulting Company who had been investing in Pfizer Inc for a number of months, seems to be bullish on the $221.17B market cap company. The stock increased 1.03% or $0.38 during the last trading session, reaching $37.18. About 8.58M shares traded. Pfizer Inc. (NYSE:PFE) has risen 2.43% since April 24, 2017 and is uptrending. It has underperformed by 9.12% the S&P500.

Investors sentiment increased to 1.06 in 2017 Q4. Its up 0.10, from 0.96 in 2017Q3. It increased, as 51 investors sold PFE shares while 675 reduced holdings. 134 funds opened positions while 632 raised stakes. 4.07 billion shares or 0.28% more from 4.06 billion shares in 2017Q3 were reported. 37,841 are owned by Hall Laurie J Trustee. Adell Harriman And Carpenter Inc stated it has 1.09% in Pfizer Inc. (NYSE:PFE). Moreover, Eubel Brady And Suttman Asset Mgmt Inc has 0.07% invested in Pfizer Inc. (NYSE:PFE). Commercial Bank Of Nova Scotia holds 0.15% in Pfizer Inc. (NYSE:PFE) or 38,645 shares. Montag A & Associates owns 0.66% invested in Pfizer Inc. (NYSE:PFE) for 187,467 shares. Oarsman Capital invested in 0.56% or 35,867 shares. Solaris Asset Ltd Liability Corporation owns 15,535 shares. 3,718 are owned by Cypress Management Ltd Liability (Wy). Massmutual Tru Fsb Adv accumulated 2,666 shares or 0% of the stock. Moreover, Peoples Svcs has 2.37% invested in Pfizer Inc. (NYSE:PFE). The New Hampshire-based Harvest Management has invested 0.37% in Pfizer Inc. (NYSE:PFE). Sandy Spring Bank holds 0.41% or 123,588 shares. Ativo Mngmt Limited Liability Corporation invested in 0.66% or 68,410 shares. Nexus Inv Management Incorporated has invested 3.48% in Pfizer Inc. (NYSE:PFE). Jupiter Asset Mngmt Ltd holds 0.82% of its portfolio in Pfizer Inc. (NYSE:PFE) for 784,741 shares.

Among 22 analysts covering Pfizer (NYSE:PFE), 9 have Buy rating, 1 Sell and 12 Hold. Therefore 41% are positive. Pfizer had 78 analyst reports since July 29, 2015 according to SRatingsIntel. The firm earned “Buy” rating on Tuesday, September 5 by BMO Capital Markets. As per Wednesday, January 31, the company rating was maintained by Credit Suisse. The stock of Pfizer Inc. (NYSE:PFE) has “Overweight” rating given on Friday, August 28 by Piper Jaffray. The stock has “Buy” rating by Jefferies on Thursday, April 7. The rating was maintained by Jefferies on Friday, April 13 with “Hold”. The stock of Pfizer Inc. (NYSE:PFE) has “Buy” rating given on Monday, August 14 by Cowen & Co. The rating was maintained by SunTrust on Monday, October 16 with “Hold”. The firm earned “Hold” rating on Monday, June 12 by BMO Capital Markets. Morgan Stanley maintained the stock with “Neutral” rating in Friday, April 7 report. BMO Capital Markets maintained Pfizer Inc. (NYSE:PFE) on Thursday, October 19 with “Outperform” rating.

Since December 15, 2017, it had 0 buys, and 12 sales for $12.99 million activity. $998,666 worth of stock was sold by JOHNSON RADY A on Tuesday, March 13. HILL CHARLES H sold $1.52M worth of Pfizer Inc. (NYSE:PFE) on Tuesday, March 6. Dolsten Mikael had sold 69,699 shares worth $2.55M on Friday, March 9. LANKLER DOUGLAS M sold $1.84 million worth of stock or 50,000 shares. SUSMAN SALLY sold 33,368 shares worth $1.24 million. The insider LUND-JURGENSEN KIRSTEN sold $353,677.

Analysts await Humana Inc. (NYSE:HUM) to report earnings on May, 2 before the open. They expect $3.21 EPS, up 16.73% or $0.46 from last year’s $2.75 per share. HUM’s profit will be $443.26M for 23.21 P/E if the $3.21 EPS becomes a reality. After $2.06 actual EPS reported by Humana Inc. for the previous quarter, Wall Street now forecasts 55.83% EPS growth.

Among 23 analysts covering Humana (NYSE:HUM), 15 have Buy rating, 0 Sell and 8 Hold. Therefore 65% are positive. Humana had 80 analyst reports since July 30, 2015 according to SRatingsIntel. The stock of Humana Inc. (NYSE:HUM) earned “Outperform” rating by RBC Capital Markets on Friday, July 22. The stock of Humana Inc. (NYSE:HUM) has “Buy” rating given on Friday, July 14 by Bank of America. As per Monday, April 23, the company rating was maintained by Cantor Fitzgerald. The firm earned “Buy” rating on Thursday, August 3 by Credit Suisse. Credit Suisse maintained it with “Neutral” rating and $188 target in Tuesday, August 16 report. The firm has “Hold” rating given on Friday, April 21 by Jefferies. The stock has “Hold” rating by Jefferies on Tuesday, September 5. Jefferies maintained Humana Inc. (NYSE:HUM) on Friday, July 7 with “Hold” rating. IBC maintained the shares of HUM in report on Friday, March 31 with “Outperform” rating. Jefferies maintained the shares of HUM in report on Friday, October 13 with “Hold” rating.

Since December 15, 2017, it had 0 insider purchases, and 10 insider sales for $20.82 million activity. $3.86 million worth of Humana Inc. (NYSE:HUM) was sold by BROUSSARD BRUCE D. 3,727 shares were sold by MARGULIS HEIDI S, worth $1.03 million. 1,196 shares were sold by Zipperle Cynthia H, worth $326,899 on Friday, March 9. BILNEY JODY L also sold $1.75M worth of Humana Inc. (NYSE:HUM) shares. LeClaire Brian P. had sold 12,719 shares worth $3.49 million. The insider Fleming William Kevin sold 1,073 shares worth $295,450.

Humana Inc. (NYSE:HUM) Institutional Positions Chart

Leave a Reply

Your email address will not be published. Required fields are marked *